The aim of this work was to study the preparation process and the in vitro release of human
serum albumin nanoparticles stabilized by Gantrez® ES-425, which was loaded with …

Corneal neovascularization (CNV) is associated with different ocular pathologies, including
infectious keratitis, trachoma or corneal trauma. Pharmacological treatments based on the …

Bevacizumab-loaded nanoparticles (B-NP) were prepared by a desolvation process
followed by freeze-drying, without any chemical, physical or enzymatic cross-linkage …

Bevacizumab, an anti‐VEGF antibody, has demonstrated trustworthy effects in treatment of
retinal and choroidal neovascularization that both are crucial sight threatening conditions …

The rapidly growing applications of antibody-based therapeutics requires novel approaches
to develop efficient drug delivery systems in which biodegradable polymeric nanoparticles …

Corneal neovascularization (CNV) is one of the major factors for vision impairment and
blindness worldwide. The current treatment for CNV focuses primarily on topical eyedrops of …

Corneal neovascularization (CNV) is one of the common blinding factors worldwide, leading
to reduced vision or even blindness. However, current treatments such as surgical …

Majorly in ocular neovascular diseases or corneal neovascularization, the up-regulation of
vascular endothelial growth factor level has been observed. Bevacizumab is a recombinant …

Choroidal neovascularization (CNV) is among the leading causes of blindness worldwide.
Bevacizumab has demonstrated promising effects on CNV treatment; however, frequent …

Three different types of sunitinib-loaded (SUN-loaded) nanocarriers were compared, aiming
at the topical treatment of corneal neovascularization (CNV): polymeric nanospheres (NS) …